NU DAO: Open Payments
NPI 1568906063 · CORONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 36 payments from 11 companies in 2025. Trend: 2023 $477 · 2024 $808 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| COLOPLAST CORP | 20 | $150 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $114 |
| ABBVIE INC. | 3 | $66 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Verity Pharmaceuticals Inc. | 1 | $31 |
| UROGEN PHARMA, INC. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| Ferring Pharmaceuticals Inc. | 1 | $25 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $20 |
| Myriad Genetic Laboratories, Inc. | 1 | $17 |
Products named: Nubeqa, Luja Coude, BOTOX, SpeediCath, Trelstar, ADSTILADRIN, Bard Urinary Drainage Bag, GEMTESA.
Industry payments across CA — which companies pay providers there.
